[1] 中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年重庆).中华消化杂志,2013,33:581-592.
[2] Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology,2006,44:788-794.
[3] Raschke RA, Curry SC, Rempe S, et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med, 2008, 36: 2244-2248.
[4] Reynolds AS, Brush B, Schiano TD, et al. Neurological monitoring in acute liver failure. Hepatology, 2019, 70: 1830-1835.
[5] Clemmesen JO, Larsen FS, Kondrup J, et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology, 1999, 29: 648-653.
[6] Tofteng F, Hauerberg J, Hansen BA, et al. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab, 2006, 26: 21-27.
[7] Rolando N, Wade J, Davalos M, et al. The systemic inflamma-tory response syndrome in acute liver failure. Hepatology, 2000, 32: 734-739.
[8] Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology, 2004, 127: 1338-1346.
[9] Larsen FS, Adel Hansen B, Pott F, et al. Dissociated cerebral vasoparalysis in acute liver failure. A hypothesis of gradual cerebral hyperaemia. J Hepatol, 1996, 25: 145-151.
[10] Datar S, Wijdicks EF. Neurologic manifestations of acute liver failure. Handb Clin Neurol, 2014, 120: 645-659.
[11] Jalan R. Intracranial hypertension in acute liver failure: pathop-hysiological basis of rational management. Semin Liver Dis, 2003, 23: 271-282.
[12] Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging, 2010, 34: 327-331.
[13] Abdo A, Lopez O, Fernandez A, et al. Transcranial Doppler sonography in fulminant hepatic failure. Transplant Proc, 2003, 35: 1859-1860.
[14] Rabinowich L, Wendon J, Bernal W, et al. Clinical management of acute liver failure: results of an international multi-center survey. World J Gastroenterol, 2016, 22: 7595-7603.
[15] Rajajee V, Fletcher JJ, Rochlen LR, et al. Comparison of accuracy of optic nerve ultrasound for the detection of intra-cranial hypertension in the setting of acutely fluctuating vs stable intracranial pressure: post-hoc analysis of data from a prospective, blinded single center study. Crit Care, 2012, 16: R79.
[16] Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure--a controlled clinical trial. J Hepatol, 2004, 41: 89-96.
[17] Newey CR, Sarwal A, Hantus S. Continuous electroen-cephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care, 2013, 18: 261-265.
[18] Nielsen HB, Tofteng F, Wang LP, et al. Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. J Hepatol, 2003, 38: 188-192.
[19] Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl, 2005, 11: 1581-1589.
[20] European Association for the Study of the Liver. Electronic address eee, Clinical practice guidelines p, Wendon J, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol, 2017, 66: 1047-1081.
[21] Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology, 2012, 55: 965-967.
[22] Blei AT, Olafsson S, Webster S, et al. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet, 1993, 341: 157-158.
[23] Karvellas CJ, Fix OK, Battenhouse H, et al. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med, 2014, 42: 1157-1167.
[24] Strauss GI, Christiansen M, Moller K, et al. S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl, 2001, 7: 964-970.
[25] Karvellas CJ, Speiser JL, Tremblay M, et al. The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case-control study. Ann Intensive Care, 2017, 7: 99. |
